cetrorelix Injectable Solution

Brand(s)
Cetrotide
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Emd Serono, Inc. (2014-05-09)
Oldest Current Product
2000-08-11
License(s)
NDA
RxNORM
INJECTABLE SOLUTION\CETRORELIX
FDAOB
INJECTION\INJECTION\CETRORELIX\rdfq

product(s) by strength(s)

cetrorelix 0.25 mg/ml injectable solution

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)dose formapplicationspl
1440871225CetrotideNDAEmd Serono, Inc.2000-08-11CETRORELIX ACETATEKITNDA021197aca7768e-28a7-4027-b1d8-e66247665f79

application(s)

#idtitleapplicantapprovedpatentapproved drug
1NDA021197CETROTIDEEMD SERONO INC2000-08-11p6319192, PREVENTION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATIONNDA021197_001, NDA021197_002

application drug(s)

#idcategory/deprecatedingredient strength(s)dose formrldapprovedapplication
1NDA021197_001RXCETRORELIX (EQ 0.25MG BASE/ML)INJECTIONTrue2000-08-11CETROTIDE
2NDA021197_002discontinuedCETRORELIX (EQ 3MG BASE/ML)INJECTIONFalse2000-08-11CETROTIDE

patent(s)

#idexpiration dateapplication(s)
1p6319192 (view patent)2019-04-23NDA021197

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)
1aca7768e-28a7-4027-b1d8-e66247665f79 (view SPL)Cetrotide 0.25 mg (cetrorelix acetate for injection)prescriptionHuman PrescriptionEmd Serono, Inc.2014-05-096440871225

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII